Highmark medical policy is intended to serve only as a general reference resource regarding coverage for the services described. This policy does not constitute medical advice and is not intended to govern or otherwise influence medical decisions.
This policy provides information regarding the coverage of, as determined by applicable federal and/or state legislation.
This policy is designed to address medical necessity guidelines that are appropriate for the majority of individuals with a particular disease, illness or condition. Each person’s unique clinical circumstances warrant individual consideration, based upon review of applicable medical records.
The qualifications of the policy will meet the standards of the National Committee for Quality Assurance (NCQA) and the Delaware Department of Health and Social Services (DHSS) and all applicable state and federal regulations.
This medical policy outlines Highmark Health Options Duals services for Vitamin D Deficiency Screening.
Highmark Health Options Duals (HHO Duals) – Highmark Health Options Duals is designed for people with both Medicare and Medicaid. Our D-SNP Medicare Advantage HMO coverage offers the same benefits as Original Medicare, plus extra benefits, like prescription drug coverage and vision and dental care.
Prior authorization is not required.
Please review the specific National Coverage Determination (NCD), Local Coverage Determination (LCD), and/or Local Coverage Article information, as well as other CMS sources, using the links below.
Post-payment Audit Statement
The medical record must include documentation that reflects the medical necessity criteria and is subject to audit by HHO Duals at any time pursuant to the terms of your provider agreement.
Place of Service
The proper place of service for Vitamin D deficiency screening can be inpatient, outpatient, skilled nursing ( inpatient and outpatient), clinical, ambulatory surgery center, and critical access hospital.
Coverage Determination and Links
HHO Duals follows the coverage determinations made by CMS as outlined in either the NCD the state-specific LCD, and/or the LCA.
CMS Link
NCD/LCD Link
· NCD: There are currently no NCDs related to this topic.
· LCD: Assays for Vitamins and Metabolic Function (L34914)
Article Link
Billing and Coding: Assays for Vitamins and Metabolic Function (A56416)
Centers for Medicare and Medicaid Services (CMS). Local Coverage Determination (LCD)
Assays for Vitamins and Metabolic Function (L34914). Original Effective date October 1, 2015. Revision
Effective date July 1, 2020. Accessed on March 17, 2023.
Centers for Medicare and Medicaid Services (CMS). Local Coverage Article (LCA) Billing and Coding: Assays for Vitamins and Metabolic Function (A56416). Original Effective date March 28, 2019. Revision Effective date January 1, 2023. Accessed on March 17, 2023.
For questions related to this policy, contact the Highmark Government Market Policy Team at GovernmentPolicy@Highmark.com